Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2002 2
2003 1
2004 1
2005 1
2006 2
2010 3
2011 3
2012 4
2013 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 2
2020 2
2021 5
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk. De Backer G, et al. Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24. Atherosclerosis. 2019. PMID: 31054483
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
Bermejo J, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subías P, San Román JA, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, de Teresa E, González-Juanatey JR, Evangelista A, Mombiela T, González-Mansilla A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators. Bermejo J, et al. Eur Heart J. 2018 Apr 14;39(15):1255-1264. doi: 10.1093/eurheartj/ehx700. Eur Heart J. 2018. PMID: 29281101 Free PMC article. Clinical Trial.
Cardiovascular prevention in elderly patients.
Bonanad C, Fernández-Olmo R, García-Blas S, Alarcon JA, Díez-Villanueva P, Mansilla CR, García-Pardo H, Toledo P, Ayesta A, Pereira E, Carol A, Castro-Conde A, de Pablo-Zarzoso C, Martínez-Sellés M, Arrarte V, Campuzano R, Ariza-Solé A. Bonanad C, et al. Among authors: campuzano r. J Geriatr Cardiol. 2022 May 28;19(5):377-392. doi: 10.11909/j.issn.1671-5411.2022.05.004. J Geriatr Cardiol. 2022. PMID: 35722032 Free PMC article.
Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias.
SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe; Grupo de Trabajo de la SEC para la guía ESC 2019 sobre el tratamiento de las dislipemias; Revisores expertos para la ESC 2019 sobre el tratamiento de las dislipemias; Comité de Guías de la SEC. SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe, et al. Rev Esp Cardiol (Engl Ed). 2020 May;73(5):348-353. doi: 10.1016/j.rec.2019.11.019. Epub 2020 Mar 21. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32205101 English, Spanish. No abstract available.
Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice.
SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):364-369. doi: 10.1016/j.rec.2021.10.023. Epub 2022 Feb 11. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35165071 English, Spanish. No abstract available.
Comments on the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.
SEC Working Group for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy and the SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy and the SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):370-374. doi: 10.1016/j.rec.2021.11.015. Epub 2022 Jan 26. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35090861 English, Spanish. No abstract available.
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial.
Palau P, López L, Domínguez E, de La Espriella R, Campuzano R, Castro A, Miñana G, Fernández-Cisnal A, Sanchis J, Núñez J. Palau P, et al. Among authors: campuzano r. J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):681-689. doi: 10.1002/jcsm.13419. Epub 2024 Jan 15. J Cachexia Sarcopenia Muscle. 2024. PMID: 38225218 Free PMC article. Clinical Trial.
Comprehensive management of risk factors in peripheral vascular disease. Expert consensus.
Barrios V, Beato P, Brotons C, Campuzano R, Merino-Torres JF, Mostaza JM, Plana N, Rubio JA, Comellas M; CREVASP working group. Barrios V, et al. Among authors: campuzano r. Rev Clin Esp (Barc). 2022 Feb;222(2):82-90. doi: 10.1016/j.rceng.2020.11.011. Epub 2021 Jul 1. Rev Clin Esp (Barc). 2022. PMID: 34217671 Free article.
38 results